Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Unknown 2

Sponsor Class

OTHER_GOV 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Triple Negative Breast Neoplasms 2Esophageal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Advanced Gastric Adenocarcinoma 2Solid Tumor 1Small Cell Lung Carcinoma 1Small Cell Lung Cancer Extensive Stage 1Sarcoma 1NSCLC 1Mucosal Melanoma 1Esophageal Squamous Cell Carcinoma 1Esophageal Diseases 1Drug-Related Side Effects and Adverse Reactions 1Digestive System Neoplasms 1Carcinoma, Hepatocellular 1Breast Neoplasms 1

Interventions

camrelizumab 2spartalizumab 1apatinib 1S 1 (combination) 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER_GOV × Advanced Gastric Adenocarcinoma × camrelizumab × Clear all
NCT04675866 2022-04-15

Camrelizumab Combined With Albumin-bound Paclitaxel and S-1 in the Treatment of Advanced Gastric Cancer

Henan Cancer Hospital

Phase NA Unknown
46 enrolled
Gastrointestinal

Advanced Gastric Adenocarcinoma

NCT04174339 2019-11-22

PD-1 Antibody(SHR-1210) Plus Apatinib Combined With POF in Advanced Gastric Cancer

Fujian Cancer Hospital

Phase NA Unknown
20 enrolled
Gastrointestinal

Advanced Gastric Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡